Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global recombinant DNA technology market reached a value of US$ 690.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 925 Billion by 2027, exhibiting a CAGR of 4.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.
Recombinant DNA Technology Market Trends:
The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, component, application and end user.
Breakup by Product:
Medical
Therapeutic Agent
Human Protein
Vaccines
Non-Medical
Biotech Crops
Specialty Chemicals
Others
Breakup by Component:
Expression System
Cloning Vector
Breakup by Application:
Food and Agriculture
Health and Disease
Environment
Others
Breakup by End User:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).
Key Questions Answered in This Report:
How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global recombinant DNA technology market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the component?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global recombinant DNA technology market and who are the key players?
What is the degree of competition in the industry?
The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.
Recombinant DNA Technology Market Trends:
The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, component, application and end user.
Breakup by Product:
Medical
Therapeutic Agent
Human Protein
Vaccines
Non-Medical
Biotech Crops
Specialty Chemicals
Others
Breakup by Component:
Expression System
Cloning Vector
Breakup by Application:
Food and Agriculture
Health and Disease
Environment
Others
Breakup by End User:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).
Key Questions Answered in This Report:
How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global recombinant DNA technology market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the component?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global recombinant DNA technology market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Medical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Therapeutic Agent
6.1.2.2 Human Protein
6.1.2.3 Vaccines
6.1.3 Market Forecast
6.2 Non-Medical
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biotech Crops
6.2.2.2 Specialty Chemicals
6.2.2.3 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY COMPONENT
7.1 Expression System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloning Vector
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Food and Agriculture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Health and Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Environment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Biotechnology and Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cibus
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F.Hoffmann-La Roche Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 GenScript
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline plc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Horizon Discovery Group plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 New England Biolabs
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Syngene International Ltd (Biocon Limited)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Medical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Therapeutic Agent
6.1.2.2 Human Protein
6.1.2.3 Vaccines
6.1.3 Market Forecast
6.2 Non-Medical
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biotech Crops
6.2.2.2 Specialty Chemicals
6.2.2.3 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY COMPONENT
7.1 Expression System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloning Vector
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Food and Agriculture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Health and Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Environment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Biotechnology and Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cibus
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F.Hoffmann-La Roche Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 GenScript
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline plc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Horizon Discovery Group plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 New England Biolabs
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Syngene International Ltd (Biocon Limited)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players
Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players
LIST OF FIGURES
Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2021
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2021
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2021
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2021
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2021
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2021
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2021
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2021
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2021
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2021
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
